138 related articles for article (PubMed ID: 36931470)
21. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line.
Wei XD; Zhou L; Cheng L; Tian J; Jiang JJ; Maccallum J
Head Neck; 2009 Jan; 31(1):94-101. PubMed ID: 18853445
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor-β mimics the key proteome properties of CD133
Bryukhovetskiy I; Shevchenko V; Arnotskaya N; Kushnir T; Pak O; Victor Z; Zaitsev S; Khotimchenko Y; Bryukhovetskiy A; Sharma A; Sharma HS
Int Rev Neurobiol; 2020; 151():219-242. PubMed ID: 32448609
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneous phenotype of human glioblastoma: in vitro study.
Denysenko T; Gennero L; Juenemann C; Morra I; Masperi P; Ceroni V; Pragliola A; Ponzetto A; Melcarne A
Cell Biochem Funct; 2014 Mar; 32(2):164-76. PubMed ID: 23836332
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin.
Lottaz C; Beier D; Meyer K; Kumar P; Hermann A; Schwarz J; Junker M; Oefner PJ; Bogdahn U; Wischhusen J; Spang R; Storch A; Beier CP
Cancer Res; 2010 Mar; 70(5):2030-40. PubMed ID: 20145155
[TBL] [Abstract][Full Text] [Related]
25. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
[TBL] [Abstract][Full Text] [Related]
26. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells.
Bidlingmaier S; Zhu X; Liu B
J Mol Med (Berl); 2008 Sep; 86(9):1025-32. PubMed ID: 18535813
[TBL] [Abstract][Full Text] [Related]
27. IL-32γ suppresses lung cancer stem cell growth via inhibition of ITGAV-mediated STAT5 pathway.
Lee YS; Kim KC; Mongre RK; Kim JY; Kim YR; Choi DY; Song S; Yun J; Han SB; Yoon DY; Hong JT
Cell Death Dis; 2019 Jul; 10(7):506. PubMed ID: 31263095
[TBL] [Abstract][Full Text] [Related]
28. Systemic approaches identify a garlic-derived chemical, Z-ajoene, as a glioblastoma multiforme cancer stem cell-specific targeting agent.
Jung Y; Park H; Zhao HY; Jeon R; Ryu JH; Kim WY
Mol Cells; 2014 Jul; 37(7):547-53. PubMed ID: 25078449
[TBL] [Abstract][Full Text] [Related]
29. Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk.
Sun T; Patil R; Galstyan A; Klymyshyn D; Ding H; Chesnokova A; Cavenee WK; Furnari FB; Ljubimov VA; Shatalova ES; Wagner S; Li D; Mamelak AN; Bannykh SI; Patil CG; Rudnick JD; Hu J; Grodzinski ZB; Rekechenetskiy A; Falahatian V; Lyubimov AV; Chen YL; Leoh LS; Daniels-Wells TR; Penichet ML; Holler E; Ljubimov AV; Black KL; Ljubimova JY
Cancer Res; 2019 Mar; 79(6):1239-1251. PubMed ID: 30659021
[TBL] [Abstract][Full Text] [Related]
30. Smoothened Promotes Glioblastoma Radiation Resistance Via Activating USP3-Mediated Claspin Deubiquitination.
Tu Y; Chen Z; Zhao P; Sun G; Bao Z; Chao H; Fan L; Li C; You Y; Qu Y; Chen Y; Ji J
Clin Cancer Res; 2020 Apr; 26(7):1749-1762. PubMed ID: 31900278
[TBL] [Abstract][Full Text] [Related]
31. Role of sonic hedgehog signaling in migration of cell lines established from CD133-positive malignant glioma cells.
Uchida H; Arita K; Yunoue S; Yonezawa H; Shinsato Y; Kawano H; Hirano H; Hanaya R; Tokimura H
J Neurooncol; 2011 Sep; 104(3):697-704. PubMed ID: 21380601
[TBL] [Abstract][Full Text] [Related]
32. Development of a novel imaging agent using peptide-coated gold nanoparticles toward brain glioma stem cell marker CD133.
Cho JH; Kim AR; Kim SH; Lee SJ; Chung H; Yoon MY
Acta Biomater; 2017 Jan; 47():182-192. PubMed ID: 27721007
[TBL] [Abstract][Full Text] [Related]
33. Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells.
Vora P; Seyfrid M; Venugopal C; Qazi MA; Salim S; Isserlin R; Subapanditha M; O'Farrell E; Mahendram S; Singh M; Bakhshinyan D; Chokshi C; McFarlane N; Dvorkin-Gheva A; Brown KR; Murty N; Moffat J; Bader GD; Singh SK
J Neurooncol; 2019 Jul; 143(3):417-428. PubMed ID: 31115870
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
[TBL] [Abstract][Full Text] [Related]
35. Chemoresistance to 5-FU inhibited by 635 nm LED irradiation in CD133+ KB cell line.
Kim D; Park M; Jang H; Hyun H; Lim W
Lasers Med Sci; 2018 Jan; 33(1):57-66. PubMed ID: 28956217
[TBL] [Abstract][Full Text] [Related]
36. CD133 negative cancer stem cells in glioblastoma.
Beier CP; Beier D
Front Biosci (Elite Ed); 2011 Jan; 3(2):701-10. PubMed ID: 21196345
[TBL] [Abstract][Full Text] [Related]
37. In vitro characterization of CD133
Nair RM; Balla MM; Khan I; Kalathur RKR; Kondaiah P; Vemuganti GK
BMC Cancer; 2017 Nov; 17(1):779. PubMed ID: 29162051
[TBL] [Abstract][Full Text] [Related]
38. Proteins of Wnt signaling pathway in cancer stem cells of human glioblastoma.
Shevchenko V; Arnotskaya N; Zaitsev S; Sharma A; Sharma HS; Bryukhovetskiy A; Pak O; Khotimchenko Y; Bryukhovetskiy I
Int Rev Neurobiol; 2020; 151():185-200. PubMed ID: 32448607
[TBL] [Abstract][Full Text] [Related]
39. Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway.
Lai FB; Liu WT; Jing YY; Yu GF; Han ZP; Yang X; Zeng JX; Zhang HJ; Shi RY; Li XY; Pan XR; Li R; Zhao QD; Wu MC; Zhang P; Liu JF; Wei LX
Cancer Lett; 2016 Aug; 378(2):131-41. PubMed ID: 27208741
[TBL] [Abstract][Full Text] [Related]
40. TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction.
Tirino V; Camerlingo R; Bifulco K; Irollo E; Montella R; Paino F; Sessa G; Carriero MV; Normanno N; Rocco G; Pirozzi G
Cell Death Dis; 2013 May; 4(5):e620. PubMed ID: 23640462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
